ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,657Medicare Part D Prescriptions Filled, Including Refills

Rank: 252 out of 676

$406K Total Retail Price of All Prescriptions

Rank: 274 out of 676

357 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 357 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

32% of this provider’s 357 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 5,517 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 642 274 S3 1 1
OMEPRAZOLE 401 256 2 2
SIMVASTATIN 310 203 3 6
ZOLPIDEM TARTRATE 221 99 4 21
GLIPIZIDE XL 219 151 5 177
NEXIUM 168 124 6 23
TRIAMTERENE-HCTZ 167 104 7 43
LISINOPRIL 154 106 8 5
METOPROLOL SUCCINATE 149 123 9 14
FUROSEMIDE 144 110 10 4
GABAPENTIN 137 95 11 10
MELOXICAM 128 81 12 13
AMLODIPINE BESYLATE 125 84 13 3
GLIPIZIDE ER 117 91 14 103
NAPROXEN 110 77 15 71
CYMBALTA 107 42 16 47
HYDROCHLOROTHIAZIDE 104 79 17 12
METOPROLOL TARTRATE 104 70 17 22
ATENOLOL 104 75 17 25
METFORMIN HCL 96 59 20 8
LEVOTHYROXINE SODIUM 88 61 21 7
CLOPIDOGREL 88 81 21 28
PLAVIX 88 79 21 40
ATORVASTATIN CALCIUM 81 58 24 20
CLONIDINE HCL 81 55 24 32
LYRICA 78 15 26 57
CAPTOPRIL 78 36 26 220
DOXYCYCLINE HYCLATE 75 48 28 82
PROMETHAZINE HCL 75 38 R 28 75
POTASSIUM CHLORIDE 74 57 30 9
CARVEDILOL 73 67 31 15
JANUVIA 73 44 31 78
DIOVAN 70 48 33 37
ROPINIROLE HCL 69 51 34 85
VYTORIN 66 61 35 176
WARFARIN SODIUM 64 64 36 18
MECLIZINE HCL 62 44 37 83
PROAIR HFA 59 36 38 79
TIZANIDINE HCL 59 17 38 68
OXYCODONE-ACETAMINOPHEN 58 42 S2 40 263
SYNTHROID 55 40 41 48
IBUPROFEN 55 12 41 102
OXYCODONE HCL-ACETAMINOPHEN 53 29 S2 43 139
ENDOCET 52 20 S2 44 104
CARISOPRODOL 52 14 R 44 60
AMOX TR-POTASSIUM CLAVULANATE 52 30 44 136
PANTOPRAZOLE SODIUM 51 28 47 42
TRICOR 51 19 47 126
ISOSORBIDE MONONITRATE ER 50 34 49 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 30, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.